CastleArk Alternatives’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-292,850
Closed -$9.46M 187
2021
Q3
$9.46M Buy
+292,850
New +$9.46M 0.36% 79